RE:Eight Capital: Buy rating and C$1.00 target price for DMTSo 8 Capital has doubled down on Small Pharma Inc. (Reiterated price target of $1)
Just a few months ago Roth & Canaccord doubled down reiterating their price targets.
HC Wainwright & Co last November Issued a price target of $2.50
HC Wainwright & Co. Initiates Coverage On Small Pharma ...https://www.benzinga.com › news › hc-wainwright-co-i... Key Insiders are loading.
Breakout vol - technical breakout.
Oh boy.
Kind Regards To All
Fish Rippah
Small Pharma Gets Big Price Target From Two Analysts): The DMT-focused firm has received Buy ratings from both Roth Capital and Canaccord Genuity. Roth has given Small Pharma a $5 price target, a spectacularly bullish prediction considering the share is currently under $0.20. Canaccord was somewhat more conservative, with a still very bullish $1 target (over 4x the current price).